CE597A31C6E1152287258A1B00678DAE Hearing Summary CLICS/CLICS2023A/commsumm.nsf PUBLICBILL SUMMARY For PRESCRIPTION DRUG MONITORING PROGRAMINTERIM COMMITTEE OPIOID AND OTHER SUBSTANCE USE DISORDERS STUDY COMMITTEEDate Aug 30, 2023 Location SCR 357 Prescription Drug Monitoring Program - Committee Discussion Only 12:20:02 PM Jason Hoppe, CU School of Medicine, spoke about the Prescription Drug Monitoring Program (PDMP) and barriers that it faces. He spoke about legislative changes and language around research and public health that creates barriers. Samuel Delp, Department of Regulatory Agencies, spoke about the finding the task force has found through the PDMP. He spoke about PDMP registration rates and requirements in the states. 12:41:36 PM Diane Matt, Colorado Veterinary Medical Association, spoke about the requirements for veterinarians to have substance abuse training and the connection between veterinary care and substance abuse. She raised concerns for a lack of clarity on how PDMP laws may affect veterinarians. She spoke about the importance of Xylazine still being available for veterinary use.
